Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
CNY 20.53
(3.53%)
CNY 20.53
(3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.41 Billion | 2.33 Billion | 2.96 Billion | 2.36 Billion | 2.07 Billion | 1.65 Billion |
| Cost of Revenue | 1.73 Billion | 1.29 Billion | 1.24 Billion | 740.65 Million | 557.35 Million | 472.24 Million |
| Gross Profit | -322.77 Million | 1.03 Billion | 1.72 Billion | 1.62 Billion | 1.51 Billion | 1.18 Billion |
| Operating Expenses | 1.54 Billion | 902.09 Million | 1.38 Billion | 1.24 Billion | 1.19 Billion | 892.42 Million |
| Selling, General and Administrative Expenses | 524.43 Million | 671.68 Million | 1.15 Billion | 1.04 Billion | 1 Billion | 738.23 Million |
| Research and Development Expenses | 158.82 Million | 145.01 Million | 150.62 Million | 127.54 Million | 135.91 Million | 98.88 Million |
| Other Expenses | 98.64 Million | -2.33 Million | -1.58 Million | -7.63 Million | -1.24 Million | -1.27 Million |
| Cost and Expenses | 2.63 Billion | 2.2 Billion | 2.63 Billion | 1.98 Billion | 1.75 Billion | 1.36 Billion |
| Operating Income | -1.22 Billion | 20.45 Million | 261.99 Million | 309.19 Million | 262.4 Million | 172.68 Million |
| Interest Expense | 99.53 Million | 93.04 Million | 62.29 Million | 55.8 Million | 46.59 Million | 41.98 Million |
| Income Tax Expense | 16.45 Million | 7.96 Million | 29.14 Million | 50.41 Million | 38.73 Million | 39.2 Million |
| Earnings before Tax | -1.23 Billion | 18.11 Million | 260.4 Million | 301.55 Million | 261.16 Million | 171.41 Million |
| Net Income | -1.24 Billion | 17.51 Million | 233.57 Million | 252.84 Million | 225.28 Million | 139.98 Million |
| Earnings Per Share Basic | -1.35 | 0.02 | 0.25 | 0.28 | 0.24 | 0.15 |
| Earnings Per Share Diluted | -1.35 | 0.02 | 0.25 | 0.28 | 0.24 | 0.15 |
| Weighted Average Shares Outstanding | 918.67 Million | 919.06 Million | 919.06 Million | 919.06 Million | 934.96 Million | 933.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 918.67 Million | 919.06 Million | 919.06 Million | 919.06 Million | 934.96 Million | 933.24 Million |
| Gross Margin | -0.23 | 0.44 | 0.58 | 0.69 | 0.73 | 0.71 |
| EBIT Margin | -0.75 | 0.08 | 0.13 | 0.18 | 0.18 | 0.20 |
| Profit Margin | -0.88 | 0.01 | 0.08 | 0.11 | 0.11 | 0.08 |
| EBITDA | -1.05 Billion | 168.09 Million | 378.5 Million | 412.64 Million | 360.04 Million | 258.94 Million |
| Earnings Before Tax Margin | -0.87 | 0.01 | 0.09 | 0.13 | 0.13 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 216.24 Million | 270.55 Million | 294.31 Million | 1.41 Billion | 270.82 Million | 319.24 Million |
| Cost of Revenue | 164.66 Million | 225.3 Million | 259.32 Million | 1.09 Billion | 308.59 Million | 276.76 Million |
| Gross Profit | 51.57 Million | 45.24 Million | 34.99 Million | 317.37 Million | -37.77 Million | 42.47 Million |
| Operating Expenses | 46.17 Million | 32.86 Million | 70.86 Million | 791.53 Million | 227.27 Million | 185.01 Million |
| Selling, General and Administrative Expenses | 100.31 Million | 31.48 Million | 53.71 Million | - | 93.03 Million | 192.25 Million |
| Research and Development Expenses | 4.15 Million | 1.38 Million | 16.43 Million | - | 58.26 Million | 30.49 Million |
| Other Expenses | -58.29 Million | -1.35 Million | 10.65 Thousand | -5.36 Million | -4.71 Million | -421.25 Thousand |
| Cost and Expenses | 210.84 Million | 258.17 Million | 330.18 Million | 1.88 Billion | 535.87 Million | 461.78 Million |
| Operating Income | -13.27 Million | 12.38 Million | -59.52 Million | -1.22 Billion | -820.04 Million | -243.16 Million |
| Interest Expense | 22.07 Million | 27.72 Million | 18.89 Million | 96.41 Million | 19.02 Million | 28.67 Million |
| Income Tax Expense | 947.36 Thousand | -1.14 Million | 2.49 Million | 16.45 Million | 28.44 Million | -9.84 Million |
| Earnings before Tax | 20.04 Million | 13.95 Million | -59.51 Million | -1.23 Billion | -824.76 Million | -243.58 Million |
| Net Income | 54.19 Million | 14.76 Million | -61.66 Million | -1.24 Billion | -851.88 Million | -232.45 Million |
| Earnings Per Share Basic | 0.06 | 0.02 | -0.07 | - | -0.95 | -0.25 |
| Earnings Per Share Diluted | 0.06 | 0.02 | -0.07 | - | -0.95 | -0.25 |
| Weighted Average Shares Outstanding | 919.06 Million | 919.06 Million | 919 Million | 918.67 Million | 900.9 Million | 919.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 919.06 Million | 919.06 Million | 919 Million | 918.67 Million | 900.9 Million | 919.06 Million |
| Gross Margin | 0.24 | 0.17 | 0.12 | 0.23 | -0.14 | 0.13 |
| EBIT Margin | 0.19 | 0.14 | -0.14 | - | -0.99 | -0.45 |
| Profit Margin | 0.25 | 0.05 | -0.21 | -0.88 | -3.15 | -0.73 |
| EBITDA | 42.12 Million | 38.65 Million | -39.76 Million | - | -267.43 Million | -144.05 Million |
| Earnings Before Tax Margin | -0.06 | 0.05 | -0.20 | -0.87 | -3.03 | -0.76 |
0HJL
0966
WBS-PG
BARODARY
LINC
STSN